GPT and COVID-19: On the second day after receiving TCZ treatment, ALT increased from normal level to 1541U/L, AST increased from normal level to 1076U/L, and a few days after drug withdrawal, liver function returns, which shows that TCZ treatment can lead to liver damage in COVID-19 patients [40].